GSA Capital Partners LLP acquired a new stake in National Research Co. (NASDAQ:NRC – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,457 shares of the company’s stock, valued at approximately $330,000. GSA Capital Partners LLP owned 0.06% of National Research as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of NRC. Principal Financial Group Inc. acquired a new stake in National Research during the third quarter worth about $248,000. US Bancorp DE grew its holdings in National Research by 2.2% during the third quarter. US Bancorp DE now owns 45,932 shares of the company’s stock worth $1,050,000 after acquiring an additional 992 shares during the period. Semanteon Capital Management LP acquired a new stake in National Research during the third quarter worth about $214,000. Creative Planning grew its holdings in National Research by 191.7% during the third quarter. Creative Planning now owns 35,557 shares of the company’s stock worth $813,000 after acquiring an additional 23,367 shares during the period. Finally, Willis Investment Counsel grew its holdings in National Research by 61.8% during the third quarter. Willis Investment Counsel now owns 56,153 shares of the company’s stock worth $1,284,000 after acquiring an additional 21,451 shares during the period. 47.26% of the stock is owned by institutional investors and hedge funds.
National Research Stock Down 1.7 %
National Research stock opened at $19.12 on Friday. The firm has a market cap of $448.86 million, a price-to-earnings ratio of 16.92 and a beta of 0.51. National Research Co. has a 52 week low of $17.62 and a 52 week high of $42.19. The business’s 50-day moving average price is $19.96 and its 200 day moving average price is $23.24. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30.
National Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a $0.12 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.51%. National Research’s dividend payout ratio (DPR) is presently 42.48%.
About National Research
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Read More
- Five stocks we like better than National Research
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Tesla Investors Continue to Profit From the Trump Trade
- Investing in Travel Stocks Benefits
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.